This is particularly important since IGRA based on the enzyme-linked immunospot (ELISPOT) technique appear not to lose sensitivity at lower CD4 counts [29,30] although the impact of progressive HIV-related immunodeficiency on IGRA accuracy is still under study. This evidence concerns the gene CD4 and immune system disorder.